Q1 sales on plan, profit ahead: can the gap be maintained through H1?

In Q1 of the fiscal year ending March 2027, revenue was ¥1,434 million, down 2.2% year on year, while operating profit rose 19.3% to ¥192 million and ordinary profit rose 27.3% to ¥189 million. Revenue was below the prior-year level, but profit increased at both the operating and ordinary profit levels. However, profit attributable to owners of the parent fell 49.4% to ¥110 million, meaning that the various stages of the income statement did not all move in the same direction.

The full-year forecast is revenue of ¥6,000 million, operating profit of ¥500 million, ordinary profit of ¥480 million and net profit of ¥330 million. The materials show Q1 progress rates of 23.9%, 38.6%, 39.4% and 33.5%, respectively. Operating profit progress was 14.7 percentage points ahead of revenue progress, indicating that profit was ahead at the Q1 stage. However, the company has not provided numerical details on seasonality or the allocation of earnings between the first and second halves, so the full-year outlook cannot be assessed based on these progress rates alone.

If 50% of the full-year forecast is used simply as the FY2027-H1 benchmark, the cumulative H1 reference points would be revenue of ¥3,000 million, operating profit of ¥250 million, ordinary profit of ¥240 million and net profit of ¥165 million. Working back from Q1 results, this would require standalone Q2 revenue of ¥1,566 million, operating profit of ¥58 million, ordinary profit of ¥51 million and net profit of ¥55 million. These are not the company's disclosed H1 targets, but benchmarks derived mechanically by dividing the full-year forecast across two six-month periods. In the actual results, the combination of Q2 revenue and profit margins will need to be assessed.

The company attributes the Q1 increase in operating profit to growth in high-value-added products and control of selling, general and administrative expenses. However, it has not disclosed the contribution of each factor to the increase, the amount of SG&A expenses or SG&A expenses as a percentage of revenue. Nor has it disclosed the numerical assumptions or risk amounts for raw material prices, foreign exchange and volume incorporated into the earnings forecast, or its own assessment against plan. In FY2027-H1, we will assess not only whether revenue reaches around ¥3,000 million, but also which products, segments and expense items generated the ¥250 million in operating profit and whether the company provides additional disclosure supporting its decision to maintain the full-year forecast.